News
Design Therapeutics to Announce Phase 1/2 RESTORE-FA Trial Data for DT-216 P2 in Friedreich's Ataxia on May 18, 2026 | DSGN Stock News
13+ hour, 16+ min ago (230+ words) Design Therapeutics will present Phase 1/2 trial data for DT-216 P2 in Friedreich's ataxia on May 18, 2026. The RESTORE-FA trial evaluates the efficacy of DT-216 P2 in patients with Friedreich's ataxia, a serious genetic disease. Design Therapeutics will announce data from the ongoing Phase…...
VEON Ltd. Subsidiary Initiates Investor Meetings for Potential US Dollar Medium Term Notes Offering | VEON Stock News
just now (303+ words) VEON's subsidiary plans investor meetings for a potential offering of unsecured medium-term notes to optimize capital structure. VEON's offering aims to extend its average debt maturity and optimize its capital structure. The proceeds will primarily fund the purchase of outstanding…...
Government Contract Update: $36 M payment to MCKESSON CORPORATION | MCK Stock News
12+ min ago (190+ words) We just received data on a $36 M payment to MCKESSON CORPORATION from the Department of Health and Human Services. This payment was made on 2026-05-15 by the Indian Health Service. We received this data from USASpending. gov. Our code mapped this…...
We Ride's WRD 3. 0 Achieves Historic Fifth Consecutive Win at Second China Urban Intelligent Driving Competition with Chery Exeed Sterra ES | WRD Stock News
1+ hour, 31+ min ago (381+ words) Chery Exeed Sterra ES, using We Ride's WRD 3. 0, wins Hefei competition, marking five consecutive victories for the ADAS solution. The Chery Exeed Sterra ES won first place, with a score of 102. 81 points, marking WRD 3. 0's fifth consecutive win. WRD 3. 0 is…...
Insider Sale: Director at $GOOGL Sells 102 Shares | GOOGL Stock News
1+ mon, 2+ week ago (238+ words) FRANCES ARNOLD, a director at $GOOGL, sold 102 shares of the company on 03-30-2026 for an estimated $28, 069. We received data on the trade from a recent SEC filing. This was a sale of approximately 0. 6% of their shares of this class of stock....
Quantum Bio Pharma Ltd. Achieves Halfway Point in Collaborative MS Imaging Study with Massachusetts General Hospital | QNTM Stock News
1+ hour, 55+ min ago (279+ words) Quantum Bio Pharma announces halfway enrollment in a study with MGH validating a new PET imaging technique for multiple sclerosis. Quantum Bio Pharma announced that patient enrollment in its study with Massachusetts General Hospital has reached the halfway mark. The…...
APPLIED MATERIALS ($AMAT) Releases Q2 2026 Earnings, Stock Rises
3+ day, 12+ hour ago (256+ words) APPLIED MATERIALS ($AMAT) posted quarterly earnings results for Q2 2026 on Thursday, May 14th. The company reported earnings of $2. 86 per share, beating estimates of $2. 71 by $0. 15. The company also reported revenue of $7, 910, 000, 000, beating estimates of $7, 823, 016, 245 by $86, 983, 755. Stock price change since market close: +3. 69% You can…...
China Signals Rare Earth Supply Relief for US Firms Following Trump-Xi Beijing Summit | BA Stock News
4+ hour, 26+ min ago (234+ words) China Signals Rare Earth Supply Relief for US Firms Following Trump-Xi Beijing Summit Quiver Quantitative China Signals Rare Earth Supply Relief for US Firms Following Trump-Xi Beijing Summit By: Matthew Kerr, Quiver Data Analyst China said it will address U. S. concerns…...
OTAIU - Congress Trading
12+ hour, 47+ min ago (12+ words) Quiver Quantitative No Congressional activity found for this ticker....
Press Release: Congresswoman Uifa'atali Amata Receives Second FEMA Grant for COVID-19 Response in American Samoa | Stock News
8+ hour, 52+ min ago (312+ words) Congresswoman Amata announces a $324, 917 FEMA grant for American Samoa's COVID-19 response efforts. Congresswoman Amata announces FEMA funding: Congresswoman Uifa'atali Amata has received a second FEMA grant of $324, 917 from the Department of Homeland Security to reimburse American Samoa for COVID-19 response…...